Case number 1:18-cv-01786
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Annora Pharma Private Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 10, 2020 | N/A | Terminated Case (0) Docket Text: CASES CLOSED per the entry of the Consent Judgment in Lead Case No. 18-1689-CFC. Associated Cases: 1:18-cv-01786-CFC-SRF, 1:19-cv-01594-CFC, 1:20-cv-00277-CFC(nmf) |
| Mar 25, 2019 | 25 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Mary Kathryn Hodges Harmon on behalf of Annora Pharma Private Limited (Harmon, Mary Kathryn) |
| Mar 5, 2019 | 24 | Scheduling Order (21) Docket Text: SCHEDULING & CONSOLIDATION ORDER: These actions are consolidated for all purposes and all papers shall be filed in Lead Case No. 18-1689-CFC. Case referred to the Magistrate Judge for the purpose of exploring ADR. Case referred to the Magistrate Judge for all disputes relating to discovery matters and protective orders. Joinder of Parties due by 4/30/2020. Amended Pleadings due by 4/30/2020. Fact Discovery completed by 3/22/2020. Joint Claim Construction Brief due by 2/28/2020. A Markman Hearing is set for 4/7/2020 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. A Final Pretrial Conference is set for 4/8/2021 at 04:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 4/19/2021 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 3/4/2019. Associated Cases: 1:18-cv-01689-CFC et al.(nmf) |
| Mar 5, 2019 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-01689-CFC-SRF. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE 18-1689-CFC ONLY. (nmf) |
| Mar 5, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Sherry R Fallon for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:18-cv-01689-CFC-SRF et al.(cak) |
| Mar 4, 2019 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 3/4/2019. (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-01689-CFC et al.(nmf) |
| Feb 28, 2019 | 23 | Letter to The Honorable Colm F. Connolly (2) |
| Feb 28, 2019 | N/A | Set/Reset Hearings (0) Docket Text: Reset Hearings: The Scheduling Conference on 3/4/2019 at 02:30 PM before Judge Colm F. Connolly is rescheduled as a Telephonic Scheduling Conference per the letter and proposed scheduling order filed today stating that there are no areas of dispute. Associated Cases: 1:18-cv-01689-CFC et al.(nmf) |
| Feb 28, 2019 | 23 | Proposed Order (21) Docket Text: PROPOSED ORDER -- [Proposed] Scheduling Order -- by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # (1) Letter to The Honorable Colm F. Connolly)(Egan, Brian) |
| Feb 8, 2019 | 22 | Answer to Counterclaim (18) Docket Text: ANSWER to [19] Answer to Complaint,, Counterclaim, -- Plaintiffs' Answer to Annora Pharma Private Ltd's Counterclaims -- by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Jan 18, 2019 | 19 | Answer to Complaint (33) Docket Text: ANSWER to [1] Complaint, by Hetero USA Inc. and Annora Pharma Private Limited, COUNTERCLAIM by Annora Pharma Private Limited against Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. by Hetero USA Inc., Annora Pharma Private Limited. (Attachments: # (1) Certificate of Service)(Capuzzi, Kevin) |
| Jan 18, 2019 | 19 | Certificate of Service (1) |
| Jan 18, 2019 | 20 | Disclosure Statement (3) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hetero Drugs Limited, Corporate Parent Hetero Labs Limited for Hetero USA Inc. filed by Hetero USA Inc.. (Capuzzi, Kevin) |
| Jan 18, 2019 | 21 | Disclosure Statement (3) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hetero Labs Limited for Annora Pharma Private Limited, Annora Pharma Private Limited filed by Annora Pharma Private Limited. (Capuzzi, Kevin) |
| Jan 10, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Zaiba Baig, Manish K. Mehta, and Michael S. Weinstein for Annora Pharma Private Limited and Hetero USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ddp) |
| Jan 9, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [16] MOTION for Pro Hac Vice Appearance of Attorney Zaiba Baig filed by Hetero USA Inc., [18] MOTION for Pro Hac Vice Appearance of Attorney Manish K. Mehta filed by Annora Pharma Private Limited, Hetero USA Inc., [17] MOTION for Pro Hac Vice Appearance of Attorney Michael S. Weinstein filed by Annora Pharma Private Limited, Hetero USA Inc., [15] MOTION for Pro Hac Vice Appearance of Attorney Zaiba Baig filed by Annora Pharma Private Limited. Signed by Judge Colm F. Connolly on 1/9/2019. (fms) |
| Jan 8, 2019 | 17 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael S. Weinstein - filed by Annora Pharma Private Limited, Hetero USA Inc.. (Capuzzi, Kevin) |
| Jan 8, 2019 | 15 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Zaiba Baig - filed by Annora Pharma Private Limited. (Capuzzi, Kevin) |
| Jan 8, 2019 | 16 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Zaiba Baig - filed by Hetero USA Inc.. (Capuzzi, Kevin) |
| Jan 8, 2019 | 18 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Manish K. Mehta - filed by Annora Pharma Private Limited, Hetero USA Inc.. (Capuzzi, Kevin) |
| Jan 4, 2019 | 14 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Kevin M. Capuzzi on behalf of Annora Pharma Private Limited (Capuzzi, Kevin) |
| Jan 3, 2019 | 13 | Order Setting Scheduling Conference (9) Docket Text: Order Setting Scheduling Conference: A Scheduling Conference is set for 3/4/2019 at 02:30 PM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 1/3/2019. Associated Cases: 1:18-cv-01689-CFC et al.(nmf) |
| Dec 28, 2018 | 12 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Jack B. Blumenfeld regarding coordinated discovery and Markman proceedings, and to request a scheduling conference. (Blumenfeld, Jack) |
| Dec 17, 2018 | 10 | Order (8) Docket Text: ORDER, IT IS ORDERED that, on or before January 2, 2019, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 1/2/2019.) Signed by Judge Colm F. Connolly on 12/17/2018. Associated Cases: 1:18-cv-01689-CFC et al.(nmf) |
| Dec 17, 2018 | 11 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Kevin M. Capuzzi on behalf of Hetero USA Inc. (Capuzzi, Kevin) |
| Nov 21, 2018 | 6 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Annora Pharma Private Limited on November 16, 2018 by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Blumenfeld, Jack) |
| Nov 21, 2018 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation: For Annora Pharma Private Limited waiver sent on 11/19/2018, answer due 1/18/2019. (Blumenfeld, Jack) |
| Nov 21, 2018 | 8 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Hetero USA Inc. on November 16, 2018 by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Blumenfeld, Jack) |
| Nov 21, 2018 | 9 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation: For Hetero USA Inc. waiver sent on 11/19/2018, answer due 1/18/2019. (Blumenfeld, Jack) |
| Nov 14, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:18-cv-01757-CFC, 1:18-cv-01758-CFC, 1:18-cv-01762-CFC through 1:18-cv-01765-CFC, 1:18-cv-01779-CFC, 1:18-cv-01783-CFC, and 1:18-cv-01785-CFC through 1:18-cv-01789-CFC (rjb) |
| Nov 13, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Annora Pharma Private Limited on 11/13/2018; Hetero USA Inc. on 11/13/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (lak) |
| Nov 13, 2018 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (lak) |
| Nov 13, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,551,957 B2 ;9,949,997 B2 ;9,949,998 B2. (lak) |
| Nov 13, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/3/2018. Date of Expiration of Patent: See Attachment.Thirty Month Stay Deadline: 2/1/2022. (lak) |
| Nov 13, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak) |
| Nov 13, 2018 | 1 | Civil Cover Sheet (1) |
| Nov 13, 2018 | 1 | Exhibit 1-3 (141) |
| Nov 13, 2018 | 1 | Complaint* (1) |
